✦ LIBER ✦

Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients

✍ Scribed by Margareta Hellgren; N. Egberg; J. Eklund

Publisher: Springer
Year: 1984
Tongue: English
Weight: 446 KB
Volume: 10
Category: Article
ISSN: 1432-1238
DOI: 10.1007/bf00258064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blood component use in critically ill pa

Blood component use in critically ill patients

✍ M. P. Rao; Harsha Boralessa; C. Morgan; N. Soni; D. R. Goldhill; S. J. Brett; Ha 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

**Summary** This prospective observational study was conducted to assess the current transfusion practice in critically ill patients. One thousand two hundred and forty‐seven consecutive critically ill patients admitted between February 1999 and October 1999 were included in the study. Overall 666 (

Anaemia and red blood cell transfusion i

Anaemia and red blood cell transfusion in the critically ill patient

✍ S.A. McLellan; D.B.L. McClelland; T.S. Walsh 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Anaemia is a common finding in critically ill patients. There are often multiple causes. Obvious causes include surgical bleeding and gastrointestinal haemorrhage but many patients have no overt bleeding episodes. Phlebotomy can be a significant source of blood loss. In addition, critically ill pati

The use of a blood conservation pressure

The use of a blood conservation pressure transducer system in critically ill patients

✍ S. Thorpe; A. N. Thomas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

We tried to determine if a blood conservation pressure transducer system reduced blood transfusions, increased haemoglobin concentration or reduced line infections in critically ill patients. One hundred patients were randomly allocated to conventional or blood conserving systems attached to systemi

Plasma tissue factor and tissue factor p

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

✍ Shimura, Minori; Wada, Hideo; Wakita, Yoshihiro; Nakase, Tutomu; Hiyoyama, Katsu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ± 90 pg/ml) and TFPI (252 ± 125 ng/ml) levels wer

Plasma tissue factor and tissue factor p

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

✍ Shimura, Minori; Wada, Hideo; Wakita, Yoshihiro; Nakase, Tutomu; Hiyoyama, Katsu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer

Concomitant occurrence of disseminated i

Concomitant occurrence of disseminated intravascular coagulation and factor VIII inhibitor in a patient with prostatic cancer

✍ Dr. Usha Singal; Eberhard F. Mammen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 3 views

An 86-year-old man, diagnosed as having carcinoma of the prostate, stage D, was admitted to the hospital. Soon after admission, he developed bleeding from various sites, including intravenous puncture sites and gastrointestinal and urinary tracts. A clinical diagnosis of disseminated intravascular c